Upgrade to SI Premium - Free Trial

TD Cowen Upgrades CVS Health (CVS) to Buy

October 4, 2024 5:30 AM
TD Cowen analyst Charles Rhyee upgraded CVS Health (NYSE: CVS) from Hold to Buy with a price target of $85.00 ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Analyst Comments Analyst PT Change Hot Comments Hot Upgrades Upgrades

Next Articles